Paricalcitol
5 Inquiries
131918-61-1
Pharmaceutical Grade
99%
shanghai
RUNYAN
1G,10G,100G,1KG,5KG/plastic tube packaging
2024-10-14
Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Paricalcitol
Other Name:1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,(1R,3R,5Z)-;19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol,(1α,3β,7E,22E)-;(1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol;Paricalcitol;Zemplar;19-Nor-1,25-dihydroxyvitamin D2;1α,25-Dihydroxy-19-nor-vitamin D2;19-Nor-1α-25-dihydroxyvitamin D2;539856-25-2
CAS No.:131918-61-1
Molecular Formula:C27H44O3
InChIKeys:InChIKey=BPKAHTKRCLCHEA-UBFJEZKGSA-N
Molecular Weight:416.64
Exact Mass:416.64
EC Number:1312995-182-4
UNII:6702D36OG5
DSSTox ID:DTXSID4048640
NCI Thesaurus Code:C38693
Color/Form:White, crystalline powder
ATC Code:H - Systemic hormonal preparations, excl. sex hormones and insulins
HScode:2936299055
Categories:
Characteristics-
PSA:
60.7
XLogP3:4.5
Density:1.121±0.06 g/cm3(Predicted)
Boiling Point:564.8±50.0 °C(Predicted)
Flash Point:14℃
Refractive Index:1.609
Water Solubility:6.80e-03 g/L
Vapor Pressure:8.6X10-14 mm Hg at 25 deg C (est)
Henrys Law Constant:Henry's Law constant = 3.8X10-7 atm-cu m/mol at 25 °C (est)
Experimental Properties:Hydroxyl radical reaction rate constant = 3.6X10-10 cu cm/molecule-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 1, Oral
Acute toxicity - Category 3, Dermal
Carcinogenicity, Category 2
Reproductive toxicity, Category 2
Reproductive toxicity, Additional category for effects on or via lactation
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H300 Fatal if swallowed
H311 Toxic in contact with skin
H351 Suspected of causing cancer
H361 Suspected of damaging fertility or the unborn child
H362 May cause harm to breast-fed children
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P263 Avoid contact during pregnancy and while nursing.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P316 Get emergency medical help immediately.
P361+P364 Take off immediately all contaminated clothing and wash it before reuse.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide
-
Location:
Room 530, 5F, building 10, Xintiandi business center, Gongshu District, Hangzhou City, Zhejiang
-
Payment Terms:
100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2022
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted 
India
Paricalcitol
1.00 KG Mar 7, 2024
India
Upadacitinib
10.00 KG Mar 6, 2024
India
Ripretinib
10.00 KG Mar 6, 2024
India
URSODEOXYCHOLIC ACID
10.00 KG Mar 6, 2024
India
Acarbose
10.00 KG Mar 6, 2024 Post an enquiry for this product
